Role of Vanadium metallicum 30c in the treatment of non-alcoholic fatty liver disease.
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To compare the changes in USG findings before and after treatment.
研究概览
简要总结
Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver disorders globally,affecting individuals who do not consume alcohol in amounts considered harmful.This is an open level prospective clinical study to find out the role of vanadium metallicum 30c in the treatment of non-alcoholic fatty liver disease.Doses will be selected as per the requirement of the individualised case. Patients will be called up for follow up after 15 days interval or as per the requirement of the case.Outcome will be measured with the help of USG and change in BARD score rating scale before and after the treatment.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 20.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Patients aged between 20 to 65 years.
- •2.Both sexes are included.
- •3.Patients with any grade of fatty liver(1st grade,2nd grade,3rd grade) 4.Patients who are in regular follow up.
排除标准
- •1.Clinical or histologic evidence of alcoholic liver disease.
- •2.Patients with any other complicated disease of liver(Carcinoma etc).
- •3.Patients with any systemic disease like renal failure,hepatocellular carcinoma,valvular heart disease etc.
- •4.Patients with hepatotoxic liver due to prolonged medication.
- •5.Pregnant and lactating females with fatty liver.
- •6.Any patients who have gone through any gastric surgery.
结局指标
主要结局
To compare the changes in USG findings before and after treatment.
时间窗: 3 to 6 months
次要结局
- To evaluate the effect of vanadium metallicum 30c by using BARD score rating scale.(3 to 6 months)
研究者
Dr Deepali Sharma
State National Homoeopathic Medical College and Hospital,Lucknow